Paradigm shift in bone reconstructions: the impact of GTO

Bone reconstruction in implant dentistry faces challenges like atrophy and defects. This webinar explores the paradigm shift with OsteoBiol GTO, highlighting its handling, bone regeneration efficacy, and emerging positive effects on soft tissues via recent studies. Real clinical cases demonstrate predictable, minimally invasive outcomes.

Bone reconstruction remains a major challenge in implant dentistry, particularly in severe atrophy, post-extractive defects, sinus augmentations, or combined horizontal/vertical deficiencies. Traditional methods relying on autologous grafts or less adaptive biomaterials often lead to inconsistent results, donor-site morbidity, prolonged healing, and limited predictability.

This webinar presents a genuine paradigm shift through the innovative use of OsteoBiol GTO—a pre-hydrated, sticky, dual-phase xenograft made of collagenated heterologous cortico-cancellous granules blended with TSV Gel. GTO provides exceptional handling: superior adaptability to defect shapes (syringe delivery, putty-like moldability), immediate stability (often without membranes/screws), excellent blood clot integration due to preserved collagen, and controlled osteoconductive remodeling for predictable bone formation.

Recent studies (2024–2026) are revealing how its collagen-rich formulation positively influences peri-implant soft tissues — enhancing gingival fibroblast proliferation/migration, supporting angiogenesis, and promoting mucosal stability and esthetic outcomes. Through multiple clinical cases, the presentation illustrates how GTO transforms complex reconstructions into more predictable, minimally invasive, and reproducible procedures.

By the end of the webinar, participants will be able to:

1. Understand the unique properties of GTO and its paradigm-shifting role in bone regeneration compared to traditional grafts.
2. Identify clinical indications for GTO in various defect types and appreciate its advantages in handling and stability.
3. Evaluate emerging evidence on GTO‘s favorable impact soft tissues (fibroblast response, angiogenesis, mucosal healing).
4. Apply practical protocols from demonstrated clinical cases to improve predictability and reduce invasiveness in daily implant practice.